carnosine has been researched along with Autoimmune Diabetes in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 2 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Amigó, N; Brugnara, L; Correig, X; Fernandez, G; García, AI; Kalko, S; Marquez, S; Murillo, S; Novials, A; Pomes, J; Ribalta, J; Rodriguez, MA; Vinaixa, M | 1 |
| Jiang, L; Lei, L; Liu, XQ; Nie, ZY; Wang, S; Wu, YG; Yard, B; Zeng, HX; Zhang, Q; Zhang, SQ; Zhu, W | 1 |
| Babizhayev, MA; Deyev, AI; Lankin, VZ; Savel'Yeva, EL; Yegorov, YE | 1 |
| Achten, E; Artioli, GG; Derave, W; Everaert, I; Gualano, B; Harris, R; Junior, AH; Otaduy, MC; Roschel, H; Stegen, S; Taes, Y | 1 |
| Baelde, H; Bakker, SJ; Bartram, CR; Brinkkoetter, P; Cerna, M; de Heer, E; Fischer, C; Hammes, HP; Hohenadel, D; Janssen, B; Köppel, H; Mathieson, P; Meyer, J; Nawroth, P; Peters, V; Rind, N; Romzova, M; Rondeau, E; Rychlik, I; Saleem, MA; Sauerhoefer, S; van der Woude, FJ; Yard, BA; Zirie, M; Zschocke, J | 1 |
| Fedurco, M; Gayova, E; Kron, I; Novakova, B; Pavlisak, V; Suchozova, K | 1 |
1 review(s) available for carnosine and Autoimmune Diabetes
| Article | Year |
|---|---|
Diabetes mellitus: novel insights, analysis and interpretation of pathophysiology and complications management with imidazole-containing peptidomimetic antioxidants.
Topics: Animals; Antioxidants; Carnosine; Diabetes Complications; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Drug Design; Humans; Hyperglycemia; Imidazoles; Patents as Topic; Peptidomimetics | 2013 |
5 other study(ies) available for carnosine and Autoimmune Diabetes
| Article | Year |
|---|---|
Muscular carnosine is a marker for cardiorespiratory fitness and cardiometabolic risk factors in men with type 1 diabetes.
Topics: Biomarkers; Cardiometabolic Risk Factors; Cardiorespiratory Fitness; Carnosine; Creatine; Diabetes Mellitus, Type 1; Humans; Lipoproteins; Male; Muscle, Skeletal | 2022 |
Carnosine alleviates diabetic nephropathy by targeting GNMT, a key enzyme mediating renal inflammation and fibrosis.
Topics: Adult; Animals; Apoptosis; Biomarkers; Carnosine; Cell Survival; Cytoprotection; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Disease Models, Animal; Down-Regulation; Epithelial Cells; Extracellular Matrix; Female; Fibrosis; Glucose; Glycine N-Methyltransferase; Humans; Inflammation; Kidney; Male; Mice, Inbred C57BL; Middle Aged; Molecular Targeted Therapy; Streptozocin | 2020 |
Reduced muscle carnosine content in type 2, but not in type 1 diabetic patients.
Topics: Adult; Carnosine; Case-Control Studies; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Female; Glucose; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Muscle, Skeletal; Oxidative Stress; Prospective Studies | 2012 |
Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1.
Topics: Aged; Carnosine; Cells, Cultured; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Dipeptidases; Female; Gene Expression; Genetic Predisposition to Disease; Glucose; Humans; Kidney; Leucine; Male; Middle Aged; Repetitive Sequences, Amino Acid; RNA, Messenger; Sequence Alignment | 2005 |
[Carnosine in patients with type I diabetes mellitus].
Topics: Adult; Carnosine; Diabetes Mellitus, Type 1; Erythrocytes; Female; Humans; Male | 1999 |